D. Western Therapeutics Institute (DWTI) (4576 JP) - Q3 Follow-Up
For H-1337, DWTI completed dosing of subjects in the Phase IIb clinical trial in August, and top-line data was announced on November 18.
289 Views
D. Western Therapeutics Institute (4576 JP) - News Flash - November 19, 2024
DWTI announced topline results from its Phase 2B clinical trial of its H-1337 Ophthalmic Solution, for the treatment of elevated intraocular...
138 Views
D. Western Therapeutics Institute (4576 JP) - News Flash - Sep 5, 2024
DWTI announced that the first transplant was performed in a domestic Phase II clinical study of DWR-2206 (Indication: bullous keratopathy)
178 Views
D. Western Therapeutics Institute (DWTI) (4576 Jp) - 2Q Follow-Up
DWTI held a 1H results briefing via ZOOM webinar on Friday 8/23 at 13:30, hosted by President Hidaka. Several important points came up in his...
197 Views
D. Western Therapeutics Institute (4576 JP) - News Flash
The number of patients is 200 cases in 4 groups: H-1337 0.6% (twice daily), 1.0% (twice daily), 1.0% (once daily), and Timolol (beta blocker drug...
373 Views